2002•The British Journal of DiabetesRequires access

Sildenafil citrate in the management of diabetic erectile dysfunction

Geoffrey Ian Hackett

Open publisher page 0 citations

Abstract

The efficacy and safety of sildenafil citrate (Viagra) in the treatment of erectile dysfunction (ED) in diabetic men have been investigated in randomised, placebo-controlled trials. In all trials and across all subgroups of patients, sildenafil was associated with improvements in erectile function compared with placebo and side-effects of treatment (mainly headache, flushing and dyspepsia) were mostly transient and mild-to-moderate. Sildenafil is, therefore, concluded to be an effective and well-tolerated treatment for ED in men with diabetes.

About this research paper

What this paper is about

The efficacy and safety of sildenafil citrate (Viagra) in the treatment of erectile dysfunction (ED) in diabetic men have been investigated in randomised, placebo-controlled trials. In all trials and across all subgroups of patients, sildenafil was associated with improvements in erectile function compared with placebo and side-effects of treatment (mainly headache, flushing and dyspepsia) were mostly transient and mild-to-moderate. Sildenafil is, therefore, concluded to be an effective and well-tolerated treatment for ED in men with diabetes.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The efficacy and safety of sildenafil citrate (Viagra) in the treatment of erectile dysfunction (ED) in diabetic men have been investigated in randomised, placebo-controlled trials. In all trials and across all subgroups of patients, sildenafil was associated with improvements in erectile function compared with placebo and side-effects of treatment (mainly headache, flushing and dyspepsia) were mostly transient and mild-to-moderate. Sildenafil is, therefore, concluded to be an effective and well-tolerated treatment for ED in men with diabetes.

Key concepts: Sildenafil, Erectile dysfunction, Medicine, Placebo, Diabetes mellitus, Erectile function, Urology, Clinical trial

Related papers

Back to paper searchBrowse research topicsOriginal source
Sildenafil citrate in the management of diabetic erectile dysfunction — Research Paper | ScholarLens